Journey Medical Ownership 2024 | Who Owns Journey Medical Now?


OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

9.38%

Insider Ownership

30.81%

Retail Ownership

59.80%

Institutional Holders

24.00

Journey Medical Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC1.57%-310,248--1,749,799Jun 30, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.1.49%0.01%294,950294,950100.00%1,664,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.34%0.00%264,025-6,575-2.43%1,489,101Jun 30, 2024
AMERICAN FINANCIAL GROUP INC0.91%0.44%180,000--1,015,000Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.75%0.09%148,3229,6977.00%836,536Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC0.67%0.00%131,571102,596354.08%742,060Jun 30, 2024
ROSALIND ADVISORS, INC.0.58%0.50%114,132114,132100.00%643,704Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.48%-95,5536,4787.27%539,047Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC0.48%0.00%94,404-128,259-57.60%531,000Jun 30, 2024
NEUBERGER BERMAN GROUP LLC0.35%0.00%68,294-13,100-16.09%385,178Jun 30, 2024
WALLEYE CAPITAL LLC0.32%0.00%63,579-70,817-52.69%358,586Jun 30, 2024
GENEOS WEALTH MANAGEMENT INC.0.32%0.02%63,28063,280100.00%356,899Jun 30, 2024
INTEGRATED WEALTH CONCEPTS LLC0.31%0.00%61,35061,350100.00%346,014Jun 30, 2024
ATRIA INVESTMENTS, INC0.28%0.00%55,33755,337100.00%312,101Jun 30, 2024
BLACKROCK INC.0.26%-51,8642,4554.97%292,513Jun 30, 2024
GLADSTONE INSTITUTIONAL ADVISORY LLC0.17%0.01%33,48133,481100.00%188,833Jun 30, 2024
STATE STREET CORP0.13%-25,553--144,119,000Jun 30, 2024
BRIGHTON JONES LLC0.12%0.00%23,020--129,833Jun 30, 2024
PERKINS CAPITAL MANAGEMENT INC0.11%0.12%22,000--124,000Jun 30, 2024
NORTHERN TRUST CORP0.09%-17,654--99,569,000Jun 30, 2024

Journey Medical's largest institutional shareholder is VANGUARD GROUP INC, holding 1.57% of the company's total share outstanding, currently valued at $1.75M. The top 10 institutional shareholders own together 8.61% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ROSALIND ADVISORS, INC.0.58%0.50%114,132114,132100.00%643,704Jun 30, 2024
AMERICAN FINANCIAL GROUP INC0.91%0.44%180,000--1,015,000Jun 30, 2024
PERKINS CAPITAL MANAGEMENT INC0.11%0.12%22,000--124,000Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.75%0.09%148,3229,6977.00%836,536Jun 30, 2024
ALLEGIANCE FINANCIAL GROUP ADVISORY SERVICES LLC0.05%0.02%10,000--56,400Jun 30, 2024
GENEOS WEALTH MANAGEMENT INC.0.32%0.02%63,28063,280100.00%356,899Jun 30, 2024
TMD WEALTH MANAGEMENT, LLC0.06%0.01%11,60511,605100.00%65,452Jun 30, 2024
GLADSTONE INSTITUTIONAL ADVISORY LLC0.17%0.01%33,48133,481100.00%188,833Jun 30, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.1.49%0.01%294,950294,950100.00%1,664,000Jun 30, 2024
INTEGRATED WEALTH CONCEPTS LLC0.31%0.00%61,35061,350100.00%346,014Jun 30, 2024
BRIGHTON JONES LLC0.12%0.00%23,020--129,833Jun 30, 2024
VIRTU FINANCIAL LLC0.05%0.00%10,54210,542100.00%59,000Jun 30, 2024
ATRIA INVESTMENTS, INC0.28%0.00%55,33755,337100.00%312,101Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.34%0.00%264,025-6,575-2.43%1,489,101Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC0.48%0.00%94,404-128,259-57.60%531,000Jun 30, 2024
TRANSCENDENT CAPITAL GROUP LLC0.00%0.00%500500100.00%2,820Jun 30, 2024
ROYCE & ASSOCIATES LP0.06%0.00%12,654--71,369Jun 30, 2024
WALLEYE CAPITAL LLC0.32%0.00%63,579-70,817-52.69%358,586Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.03%0.00%4,933-105-2.08%27,822Jun 30, 2024
NEUBERGER BERMAN GROUP LLC0.35%0.00%68,294-13,100-16.09%385,178Jun 30, 2024

The largest Journey Medical shareholder by % of total assets is ROSALIND ADVISORS, INC.. The company owns 114.13K shares of Journey Medical (DERM), representing 0.50% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.1.49%0.01%294,950294,950100.00%1,664,000Jun 30, 2024
ROSALIND ADVISORS, INC.0.58%0.50%114,132114,132100.00%643,704Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC0.67%0.00%131,571102,596354.08%742,060Jun 30, 2024
GENEOS WEALTH MANAGEMENT INC.0.32%0.02%63,28063,280100.00%356,899Jun 30, 2024
INTEGRATED WEALTH CONCEPTS LLC0.31%0.00%61,35061,350100.00%346,014Jun 30, 2024
ATRIA INVESTMENTS, INC0.28%0.00%55,33755,337100.00%312,101Jun 30, 2024
GLADSTONE INSTITUTIONAL ADVISORY LLC0.17%0.01%33,48133,481100.00%188,833Jun 30, 2024
TMD WEALTH MANAGEMENT, LLC0.06%0.01%11,60511,605100.00%65,452Jun 30, 2024
VIRTU FINANCIAL LLC0.05%0.00%10,54210,542100.00%59,000Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.75%0.09%148,3229,6977.00%836,536Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.48%-95,5536,4787.27%539,047Jun 30, 2024
BLACKROCK INC.0.26%-51,8642,4554.97%292,513Jun 30, 2024
TRANSCENDENT CAPITAL GROUP LLC0.00%0.00%500500100.00%2,820Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-400400100.00%2,256Jun 30, 2024
ROYAL BANK OF CANADA0.00%-371371100.00%2,000Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC0.00%-300300100.00%1,692Jun 30, 2024
JPMORGAN CHASE & CO0.00%-20533.33%113Jun 30, 2024
STATE STREET CORP0.13%-25,553--144,119,000Jun 30, 2024
NORTHERN TRUST CORP0.09%-17,654--99,569,000Jun 30, 2024
FEDERATED HERMES, INC.0.01%-1,329--7,496,000Jun 30, 2024

As of Jun 30 2024, Journey Medical's largest institutional buyer is CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.. The company purchased 294.95K stocks of DERM, valued at $1.66M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ACADIAN ASSET MANAGEMENT LLC0.48%0.00%94,404-128,259-57.60%531,000Jun 30, 2024
WALLEYE CAPITAL LLC0.32%0.00%63,579-70,817-52.69%358,586Jun 30, 2024
XTX TOPCO LTD----36,548-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----36,117-100.00%-Jun 30, 2024
HERON BAY CAPITAL MANAGEMENT----33,669-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-71-22,585-99.69%400Jun 30, 2024
GOLDMAN SACHS GROUP INC----19,965-100.00%-Jun 30, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----15,060-100.00%-Jun 30, 2024
NEUBERGER BERMAN GROUP LLC0.35%0.00%68,294-13,100-16.09%385,178Jun 30, 2024
NWAM LLC----11,820-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.34%0.00%264,025-6,575-2.43%1,489,101Jun 30, 2024
IFP ADVISORS, INC----3,403-100.00%-Jun 30, 2024
NEWEDGE ADVISORS, LLC----2,124-100.00%-Jun 30, 2024
MORGAN STANLEY----550-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.03%0.00%4,933-105-2.08%27,822Jun 30, 2024
WELLS FARGO & COMPANY/MN----61-100.00%-Jun 30, 2024
AMERICAN FINANCIAL GROUP INC0.91%0.44%180,000--1,015,000Jun 30, 2024
PERKINS CAPITAL MANAGEMENT INC0.11%0.12%22,000--124,000Jun 30, 2024
ALLEGIANCE FINANCIAL GROUP ADVISORY SERVICES LLC0.05%0.02%10,000--56,400Jun 30, 2024
BRIGHTON JONES LLC0.12%0.00%23,020--129,833Jun 30, 2024

As of Jun 30 2024, Journey Medical's biggest institutional seller is ACADIAN ASSET MANAGEMENT LLC. The company sold -0.13M shares of DERM, valued at $531.00K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.1.49%0.01%294,950294,950100.00%1,664,000Jun 30, 2024
ROSALIND ADVISORS, INC.0.58%0.50%114,132114,132100.00%643,704Jun 30, 2024
GENEOS WEALTH MANAGEMENT INC.0.32%0.02%63,28063,280100.00%356,899Jun 30, 2024
INTEGRATED WEALTH CONCEPTS LLC0.31%0.00%61,35061,350100.00%346,014Jun 30, 2024
ATRIA INVESTMENTS, INC0.28%0.00%55,33755,337100.00%312,101Jun 30, 2024
GLADSTONE INSTITUTIONAL ADVISORY LLC0.17%0.01%33,48133,481100.00%188,833Jun 30, 2024
TMD WEALTH MANAGEMENT, LLC0.06%0.01%11,60511,605100.00%65,452Jun 30, 2024
TRANSCENDENT CAPITAL GROUP LLC0.00%0.00%500500100.00%2,820Jun 30, 2024
ROYAL BANK OF CANADA0.00%-371371100.00%2,000Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC0.00%-300300100.00%1,692Jun 30, 2024

Journey Medical's largest new institutional shareholder by number of shares is CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC., purchased 294.95K shares, valued at $1.66M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
XTX TOPCO LTD----36,548-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----36,117-100.00%-Jun 30, 2024
HERON BAY CAPITAL MANAGEMENT----33,669-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----19,965-100.00%-Jun 30, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----15,060-100.00%-Jun 30, 2024
NWAM LLC----11,820-100.00%-Jun 30, 2024
IFP ADVISORS, INC----3,403-100.00%-Jun 30, 2024
NEWEDGE ADVISORS, LLC----2,124-100.00%-Jun 30, 2024
MORGAN STANLEY----550-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----61-100.00%-Jun 30, 2024

Journey Medical's largest sold out institutional shareholder by shares sold is XTX TOPCO LTD, sold -36.55K shares, valued at -, as of undefined.

Journey Medical Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Virtus Convertible & Income Fund2.47%12,190,000--Jan 31, 2024
Virtus Convertible & Income Fund II2.44%9,210,000--Jan 31, 2024
LIBERTY ALL STAR GROWTH FUND INC.0.98%123,733--Dec 31, 2023
TRI-CONTINENTAL CORP0.97%5,200,000--Mar 31, 2024
ARBITRAGE FUNDS0.74%3,368,000--Feb 29, 2024
ALGER FUNDS II0.15%34,250--Jan 31, 2024
BUFFALO FUNDS0.15%1,000,000--Mar 31, 2024
DELAWARE GROUP EQUITY FUNDS IV0.13%150,000--Mar 28, 2024
ALGER FUNDS0.12%115,063--Jan 31, 2024
FIDELITY FINANCIAL TRUST0.11%1,920,000--Feb 29, 2024
Virtus Investment Trust0.09%3,065,000--Mar 28, 2024
TEKLA HEALTHCARE INVESTORS0.07%61,500--Mar 31, 2024
TEKLA LIFE SCIENCES INVESTORS0.06%27,700--Mar 31, 2024
LITMAN GREGORY FUNDS TRUST0.06%3,806,000--Mar 31, 2024
World Funds Trust0.04%22,000--Jan 31, 2024
Gabelli 787 Fund, Inc.0.04%3,000--Jan 31, 2024
ADVISORS' INNER CIRCLE FUND0.02%500,000--Jan 31, 2024
FRANKLIN STRATEGIC SERIES0.02%147,100--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%8,606--Mar 31, 2024
Columbia Funds Series Trust II0.01%5,500,000--Jan 31, 2024
PERRITT FUNDS INC0.01%1,678--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%72,795--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,468--Mar 31, 2024
ALGER PORTFOLIOS0.01%2,442--Dec 31, 2023
Legg Mason ETF Investment Trust0.01%12,65412,654-Mar 31, 2024
JNL VARIABLE FUND LLC0.01%35,003--Mar 31, 2020
LEGG MASON PARTNERS INCOME TRUST0.01%4,688,000--Mar 28, 2024
Forethought Variable Insurance Trust0.00%21,320--Mar 28, 2024
GABELLI EQUITY TRUST INC0.00%6,000--Dec 29, 2023
VANGUARD INDEX FUNDS0.00%1,984,048--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%480,000--Jan 31, 2024
JPMORGAN INSURANCE TRUST0.00%41,400--Mar 31, 2023
SCHWAB CAPITAL TRUST0.00%118,173--Feb 29, 2024
RUSSELL INVESTMENT CO0.00%776,000--Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%54,862--Mar 31, 2024
Virtus Investment Trust0.00%54,385--Mar 28, 2024
Calvert Variable Products, Inc.0.00%4,173--Mar 31, 2024
FIDELITY COVINGTON TRUST0.00%18,848--Jan 31, 2024
Voya INVESTORS TRUST0.00%54,000--Mar 31, 2024
Dunham Funds0.00%59,638--Jan 31, 2024
SunAmerica Specialty Series0.00%422--Apr 30, 2021
HARTFORD SERIES FUND INC0.00%33,577--Mar 31, 2024
OHIO NATIONAL FUND INC0.00%15,192--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%305,60671,71730.66%Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%22,892--Mar 31, 2024
NEUBERGER BERMAN ALTERNATIVE FUNDS0.00%9,100--Jan 31, 2024
JOHN HANCOCK INVESTMENT TRUST0.00%57,514--Mar 31, 2024
Principal Exchange-Traded Funds0.00%7,941--Mar 31, 2024
PFM Multi-Manager Series Trust0.00%400--Dec 31, 2023
VANGUARD WORLD FUND0.00%115,512--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%80,4469,36713.18%Feb 29, 2024
SCHWAB STRATEGIC TRUST0.00%169,509--Feb 29, 2024
COLUMBIA FUNDS SERIES TRUST I0.00%1,326,000--Feb 29, 2024
NORTHERN FUNDS0.00%35,427--Mar 28, 2024
TIAA-CREF LIFE FUNDS0.00%587--Mar 31, 2024
MAINSTAY VP FUNDS TRUST0.00%22,200--Mar 31, 2024
Meeder Funds0.00%790--Mar 31, 2024
TIAA-CREF FUNDS0.00%495,501--Mar 31, 2024
EQ ADVISORS TRUST0.00%190,282--Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%9,100--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%141,449--Mar 31, 2024
1290 Funds0.00%174,000--Jan 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%10,274--Mar 31, 2024
ALLSPRING MASTER TRUST0.00%6,501--Feb 29, 2024
Brighthouse Funds Trust II0.00%83,413--Mar 31, 2024
LOOMIS SAYLES FUNDS I0.00%245,000--Mar 31, 2024
VALIC Co I0.00%24,454--Feb 29, 2024
LOOMIS SAYLES FUNDS II0.00%220,000--Mar 31, 2024
EQ ADVISORS TRUST0.00%93,000--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%8,269--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%8,004--Mar 31, 2024
PENN SERIES FUNDS INC0.00%1,700--Mar 28, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%665--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%6,950--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%10,159--Feb 29, 2024
HC CAPITAL TRUST0.00%1,548--Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%92,509--Feb 29, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%1,500--Dec 31, 2023
USAA MUTUAL FUNDS TRUST0.00%6,166--Jan 31, 2024
HARTFORD MUTUAL FUNDS INC/CT0.00%212,175--Jan 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%56,968--Mar 31, 2024
Brighthouse Funds Trust I0.00%172,816--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%100--Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,935--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%6,223--Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%23,318--Mar 31, 2024
SPDR INDEX SHARES FUNDS0.00%1,461--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%6,981--Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%120--Feb 29, 2024
PACIFIC SELECT FUND0.00%17,913--Mar 31, 2024
Bridge Builder Trust0.00%18,986--Mar 31, 2024
iShares U.S. ETF Trust0.00%276--Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%496--Jan 31, 2024
BlackRock Variable Series Funds, Inc.0.00%6,291--Mar 31, 2024
WILSHIRE MUTUAL FUNDS INC0.00%300--Dec 31, 2023
EQ ADVISORS TRUST0.00%1,103--Mar 31, 2024
iSHARES TRUST0.00%14,479-380-2.56%Mar 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%7,200--Feb 29, 2024
FundVantage Trust0.00%2--Mar 28, 2024

Journey Medical's largest mutual fund holder by % of total assets is "Virtus Convertible & Income Fund", owning 12.19M shares, compromising 2.47% of its total assets.

Journey Medical Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2424-22.58%
31 Mar, 2431-8.82%
31 Dec, 233470.00%
30 Sep, 23205.26%
30 Jun, 231911.76%
31 Mar, 2317-5.56%
31 Dec, 2218-
30 Sep, 221850.00%
30 Jun, 2212-7.69%
31 Mar, 2213-7.14%
31 Dec, 2114-

As of 30 Jun 24, 24 institutions are holding Journey Medical's shares, representing a decrease of -22.58% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 241,854,1422.08%
31 Mar, 241,816,38535.41%
31 Dec, 231,341,390-37.18%
30 Sep, 232,135,26629.19%
30 Jun, 231,652,825-2.42%
31 Mar, 231,693,771-36.62%
31 Dec, 222,672,47842.26%
30 Sep, 221,878,5246.77%
30 Jun, 221,759,4317.00%
31 Mar, 221,644,2891.03%
31 Dec, 211,627,492-

Journey Medical (DERM) has 1.85M shares outstanding as of 30 Jun 24, up 2.08% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 249.38%9.46%
31 Mar, 249.96%18.94%
31 Dec, 237.25%5.16%
30 Sep, 2311.86%13.77%
30 Jun, 239.28%10.26%
31 Mar, 239.51%4.09%
31 Dec, 2215.24%13.41%
30 Sep, 2210.66%10.50%
30 Jun, 2210.08%11.18%
31 Mar, 229.49%6.29%
31 Dec, 2112.29%-

As of 30 Jun 24, Journey Medical is held by 9.38% institutional shareholders, representing a 9.46% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2413-38.10%
31 Mar, 2421-25.00%
31 Dec, 2328154.55%
30 Sep, 231137.50%
30 Jun, 238100.00%
31 Mar, 234-60.00%
31 Dec, 2210-
30 Sep, 221066.67%
30 Jun, 226-
31 Mar, 226-57.14%
31 Dec, 2114-

13 institutional shareholders have increased their position in DERM stock as of 30 Jun 24 compared to 21 in the previous quarter (a -38.10% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 244-20.00%
31 Mar, 24566.67%
31 Dec, 233-50.00%
30 Sep, 23620.00%
30 Jun, 235-28.57%
31 Mar, 237250.00%
31 Dec, 222-50.00%
30 Sep, 224-
30 Jun, 224-20.00%
31 Mar, 225-
31 Dec, 21--

4 institutional shareholders have reduced their position in DERM stock as of 30 Jun 24 compared to 5 in the previous quarter (a -20.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2424-22.58%1,854,1422.08%9.38%9.46%13-38.10%4-20.00%
31 Mar, 2431-8.82%1,816,38535.41%9.96%18.94%21-25.00%566.67%
31 Dec, 233470.00%1,341,390-37.18%7.25%5.16%28154.55%3-50.00%
30 Sep, 23205.26%2,135,26629.19%11.86%13.77%1137.50%620.00%
30 Jun, 231911.76%1,652,825-2.42%9.28%10.26%8100.00%5-28.57%
31 Mar, 2317-5.56%1,693,771-36.62%9.51%4.09%4-60.00%7250.00%
31 Dec, 2218-2,672,47842.26%15.24%13.41%10-2-50.00%
30 Sep, 221850.00%1,878,5246.77%10.66%10.50%1066.67%4-
30 Jun, 2212-7.69%1,759,4317.00%10.08%11.18%6-4-20.00%
31 Mar, 2213-7.14%1,644,2891.03%9.49%6.29%6-57.14%5-
31 Dec, 2114-1,627,492-12.29%-14---

Journey Medical Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 01, 2024Benesch Josephofficer CFOS-SaleSell9,324$5.47$51.00K47,331
Jul 23, 2024Benesch Josephofficer CFOS-SaleSell4,055$5.40$21.90K56,655
Mar 27, 2024ROSENWALD LINDSAY A MDdirector-P-PurchaseBuy10,000$3.04$30.40K144,245
Mar 25, 2024Maraoui Claudedirector, officer President & CEOP-PurchaseBuy10,000$3.48$34.79K2,163,430
Mar 25, 2024Smith Justin Adamdirector-P-PurchaseBuy30,000$3.47$104.10K134,717
Mar 25, 2024ROSENWALD LINDSAY A MDdirector-P-PurchaseBuy20,000$3.40$68.00K134,245
Feb 23, 2024Benesch Josephofficer Interim CFOS-SaleSell2,450$3.75$9.19K60,710

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 27, 2024ROSENWALD LINDSAY A MDdirector-P-PurchaseBuy10,000$3.04$30.40K144,245
Mar 25, 2024Maraoui Claudedirector, officer President & CEOP-PurchaseBuy10,000$3.48$34.79K2,163,430
Mar 25, 2024Smith Justin Adamdirector-P-PurchaseBuy30,000$3.47$104.10K134,717
Mar 25, 2024ROSENWALD LINDSAY A MDdirector-P-PurchaseBuy20,000$3.40$68.00K134,245

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 01, 2024Benesch Josephofficer CFOS-SaleSell9,324$5.47$51.00K47,331
Jul 23, 2024Benesch Josephofficer CFOS-SaleSell4,055$5.40$21.90K56,655
May 31, 2024Fortress Biotech, Inc.10 percent owner-J-OtherSell50,000--4,060,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-J-OtherSell50,000--4,010,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-J-OtherSell50,000--3,960,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-J-OtherSell50,000--3,910,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-J-OtherSell50,000--3,860,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-Sell---4,110,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-Sell6,000,000---
Feb 23, 2024Benesch Josephofficer Interim CFOS-SaleSell2,450$3.75$9.19K60,710

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 01, 2024Benesch Josephofficer CFOS-SaleSell9,324$5.47$51.00K47,331
Jul 23, 2024Pearce Michael Cooperdirector-A-AwardBuy30,000--30,000
Jul 23, 2024Benesch Josephofficer CFOS-SaleSell4,055$5.40$21.90K56,655
Jul 19, 2024Pearce Michael Cooperdirector Buy----
Jul 10, 2024Smith Justin Adamdirector-A-AwardBuy9,728--144,445
Jul 10, 2024Herskowitz Neildirector-A-AwardBuy9,728--81,445
Jul 10, 2024Toledano Miranda Jaynedirector-A-AwardBuy9,728--81,445
Jul 10, 2024ROSENWALD LINDSAY A MDdirector-A-AwardBuy9,728--153,973
May 31, 2024Fortress Biotech, Inc.10 percent owner-J-OtherSell50,000--4,060,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-J-OtherSell50,000--4,010,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-J-OtherSell50,000--3,960,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-J-OtherSell50,000--3,910,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-J-OtherSell50,000--3,860,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-Sell---4,110,467
May 31, 2024Fortress Biotech, Inc.10 percent owner-Sell6,000,000---
Mar 27, 2024ROSENWALD LINDSAY A MDdirector-P-PurchaseBuy10,000$3.04$30.40K144,245
Mar 25, 2024Maraoui Claudedirector, officer President & CEOP-PurchaseBuy10,000$3.48$34.79K2,163,430
Mar 25, 2024Smith Justin Adamdirector-P-PurchaseBuy30,000$3.47$104.10K134,717
Mar 25, 2024ROSENWALD LINDSAY A MDdirector-P-PurchaseBuy20,000$3.40$68.00K134,245
Feb 23, 2024Benesch Josephofficer Interim CFOS-SaleSell2,450$3.75$9.19K60,710

The last insider sell of Journey Medical's stock was made by Benesch Joseph on Aug 01 2024, selling 9,324 shares at $5.47 per share (valued at $51.00K). The last insider buy of DERM was made by ROSENWALD LINDSAY A MD on Mar 27 2024, buying 10,000 shares at $3.04 per share (worth $30.40K).

Journey Medical Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 202452250.00%
Q1 202441400.00%
Q4 20232366.67%
Q3 202372350.00%
Q2 2023-3-
Q1 2023-3-
Q4 20221250.00%
Q3 202271700.00%
Q2 2022-1-
Q1 20225--
Q4 2021-4-
Q1 20201721.39%
Q4 20191250.00%
Q3 201971546.67%
Q2 20192112175.00%
Q1 20196--
Q4 2018-1-
Q3 2018101471.43%
Q2 2018186300.00%
Q1 2018101283.33%

5 total buy trades, and 2 total sell trades (buy/sell ratio of 2.50%) were made by Journey Medical's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-2-
Q1 202441400.00%
Q4 20232366.67%
Q3 202332150.00%
Q2 2023-2-
Q1 2023-1-
Q4 2022-2-
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021---
Q1 20201--
Q4 2019-2-
Q3 2019-1-
Q2 2019-1-
Q1 2019---
Q4 2018-1-
Q3 2018---
Q2 2018---
Q1 2018-8-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Journey Medical's stocks.

Journey Medical Peer Ownership


TickerCompany
EVOKEvoke Pharma, Inc.
AQSTAquestive Therapeutics, Inc.
LFCRLifecore Biomedical, Inc.
ORGOOrganogenesis Holdings Inc.
ALIMAlimera Sciences, Inc.
SHPHShuttle Pharmaceuticals Holdings, Inc.
JUPWSafety Shot Inc
LSDILucy Scientific Discovery Inc.
ACBAurora Cannabis Inc.
AVDLAvadel Pharmaceuticals plc

DERM Ownership FAQ


Journey Medical is owned by institutional shareholders (9.38%), insiders (30.81%), and public (59.80%). The largest institutional shareholder of Journey Medical is VANGUARD GROUP INC (1.57% of total shares) and the top mutual fund owner is Virtus Convertible & Income Fund (2.47% of total shares).

Journey Medical's major institutional shareholders are VANGUARD GROUP INC, CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC., RENAISSANCE TECHNOLOGIES LLC, AMERICAN FINANCIAL GROUP INC, and TANG CAPITAL MANAGEMENT LLC. The top five shareholders own together 6.06% of the company's share outstanding.

As of Jun 2024, there are 24 institutional shareholders of Journey Medical.

VANGUARD GROUP INC owns 310.25K shares of Journey Medical, representing 1.57% of the company's total shares outstanding, valued at $1.75M (as of Jun 2024).

As of Jun 2024, CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC holds 294.95K shares of Journey Medical (DERM), compromising 1.49% of the company, valued at $1.66M.

RENAISSANCE TECHNOLOGIES LLC is the third largest holder of Journey Medical. The company owns 264.02K of the company's shares outstanding (worth $1.49M).